Epigenetic regulation of transcriptional programming
转录编程的表观遗传调控
基本信息
- 批准号:10398124
- 负责人:
- 金额:$ 71.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
The genomes of higher organisms are highly annotated by specific chromosomal proteins and
histone modifications along active genes, regulatory elements, or silent regions. This annotation is
critical for proper cell type specification, and an ongoing challenge is to decipher the rules that
establish and maintain chromatin organization. My laboratory focuses on analysis of chromatin
regulatory complexes, based on their central importance in development and disease, the intriguing
hypotheses raised by our recent studies, and our ability to use new approaches to probe chromatin
protein interactions with precision. Historically, we have made significant contributions to
understanding the targeting and spreading of chromatin domains, and currently we are probing the
ability of chromatin factors to poise genes for key regulatory decisions that specify cell type. Our
current studies focus on the Polycomb group (PcG) proteins, and due to the high conservation of this
key regulatory system we move between fly embryos and human embryonic stem cells with ease. We
are developing a model in which key regulatory genes are universally ‘poised’ early in development
via occupancy of composite protein complexes of Polycomb Repressive Complex 1 (PRC1) and
classical co-activators. These ‘bivalent’ protein complexes may resolve into full activation or
repression, depending on the cell type-specific expression, binding, and function of transcription
factors. We speculate that transcription factors may bind relatively promiscuously, but still execute
precise regulatory decisions, when they influence the local acetylation/deacetylation state at these
predetermined sites. Our speculative model is based on strong proteomic evidence that PRC1
strongly interacts with classic co-activators, dBRD4 and dMOZ/MORF, captured on chromatin during
embryogenesis in Drosophila, and by analogous co-occupancy of CBX7, RING2 (subunits of PRC1),
and BRD1 (a subunit of MOZ/MORF) in human embryonic stem cells. We believe that we are on the
cusp of understanding chromatin transitions and transcriptional programming at a mechanistic level.
These studies also synergize with our molecular dissection of aberrant chromatin complexes that
drive human cancers.
项目摘要
较高生物体的基因组由特定的染色体蛋白和
沿活动基因,调节元素或无声区域的组蛋白修饰。该注释是
对于适当的单元类型规范至关重要,而持续的挑战是破译规则
建立和维护染色质组织。我的实验室专注于染色质的分析
监管复合物基于其在发育和疾病中的核心重要性,有趣
我们最近的研究提出的假设以及使用新方法探测染色质的能力
蛋白质相互作用与精度相互作用。从历史上看,我们为
了解染色质域的靶向和扩散,目前我们正在探测
染色质因子能够为指定细胞类型的关键调节决策固定基因。我们的
当前的研究重点是Polycomb组(PCG)蛋白,并且由于对此有很高的保护
关键调节系统我们轻松地在蝇胚和人类胚胎干细胞之间移动。我们
正在开发一个模型,其中关键的监管基因在开发初期普遍“有利”
通过占用Polycomb抑制复合物1(PRC1)的复合蛋白复合物和
古典共同激活剂。这些“二动”蛋白络合物可能会完全激活或
抑制,取决于细胞类型特异性的表达,转录的结合和功能
因素。我们推测转录因子可能会相对滥交,但仍执行
精确调节决策,当它们影响局部乙酰化/脱乙酰化状态时
预定位点。我们的投机模型基于强有力的蛋白质组学证据表明PRC1
与经典的共激活因子DBRD4和DMOZ/MORF强烈相互作用,在染色质上捕获
果蝇中的胚胎发生,并通过CBX7,RING2(PRC1的亚基)的类似同居
和人类胚胎干细胞中的BRD1(MOZ/MORF的亚基)。我们相信我们正在
理解染色质转变和转录编程的尖端。
这些研究还与我们对异常染色质复合物的分子解剖协同作用
推动人类癌症。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cell state-dependent chromatin targeting in NUT carcinoma.
NUT 癌中细胞状态依赖性染色质靶向。
- DOI:10.1093/genetics/iyad083
- 发表时间:2023
- 期刊:
- 影响因子:3.3
- 作者:Alekseyenko,ArtyomA;Zee,BarryM;Dhoondia,Zuzer;Kang,Hyuckjoon;Makofske,JessicaL;Kuroda,MitziI
- 通讯作者:Kuroda,MitziI
Variant Polycomb complexes in Drosophila consistent with ancient functional diversity.
- DOI:10.1126/sciadv.add0103
- 发表时间:2022-09-09
- 期刊:
- 影响因子:13.6
- 作者:
- 通讯作者:
共 2 条
- 1
Mitzi I Kuroda的其他基金
Epigenetic regulation of transcriptional programming
转录编程的表观遗传调控
- 批准号:1015551610155516
- 财政年份:2018
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Epigenetic regulation of transcriptional programming
转录编程的表观遗传调控
- 批准号:99223219922321
- 财政年份:2018
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Comprehensive analysis of epigenetic regulators in their native chromatin context
表观遗传调节因子在其天然染色质环境中的综合分析
- 批准号:83216758321675
- 财政年份:2012
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Comprehensive analysis of epigenetic regulators in their native chromatin context
表观遗传调节因子在其天然染色质环境中的综合分析
- 批准号:85989158598915
- 财政年份:2012
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Comprehensive analysis of epigenetic regulators in their native chromatin context
表观遗传调节因子在其天然染色质环境中的综合分析
- 批准号:90371419037141
- 财政年份:2012
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Comprehensive analysis of epigenetic regulators in their native chromatin context
表观遗传调节因子在其天然染色质环境中的综合分析
- 批准号:87887108788710
- 财政年份:2012
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Comprehensive analysis of epigenetic regulators in their native chromatin context
表观遗传调节因子在其天然染色质环境中的综合分析
- 批准号:84593968459396
- 财政年份:2012
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Molecular Genetics of Dosage Compensation in Drosophila
果蝇剂量补偿的分子遗传学
- 批准号:79017677901767
- 财政年份:2009
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Molecular Genetics of Dosage Compensation in Drosophila
果蝇剂量补偿的分子遗传学
- 批准号:64018736401873
- 财政年份:2001
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Molecular Genetics of Dosage Compensation in Drosophila
果蝇剂量补偿的分子遗传学
- 批准号:65301136530113
- 财政年份:2001
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
相似国自然基金
TAZ诱导与ASCL1增强子结合的H3K27ac去乙酰化、抑制胶质瘤干细胞神经元分化的机制研究
- 批准号:82303004
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
HIF-3α结合NCOA1抑制组蛋白乙酰化促进神经细胞铁死亡在缺血性脑卒中的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
乙酰化修饰的硒结合蛋白SELENBP1参与调控乳腺癌细胞铁死亡的分子机制
- 批准号:82273169
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
HIF-3α结合NCOA1抑制组蛋白乙酰化促进神经细胞铁死亡在缺血性脑卒中的机制研究
- 批准号:82260418
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
乙酰化修饰的硒结合蛋白SELENBP1参与调控乳腺癌细胞铁死亡的分子机制
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Cancer-based discovery of novel mechanisms of chromatin control
基于癌症的染色质控制新机制的发现
- 批准号:1066068010660680
- 财政年份:2023
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Mechanism of Transcriptional Regulation of Th2 Cell Development
Th2细胞发育的转录调控机制
- 批准号:1071601410716014
- 财政年份:2023
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:1072726810727268
- 财政年份:2023
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Configuration-specific cofactors of Oct4
Oct4 的配置特定辅因子
- 批准号:1071359210713592
- 财政年份:2023
- 资助金额:$ 71.76万$ 71.76万
- 项目类别:
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
完整项目 1:MICAL 依赖性胰腺癌细胞迁移的定义机制
- 批准号:1076227310762273
- 财政年份:2023
- 资助金额:$ 71.76万$ 71.76万
- 项目类别: